Talk:Epinephrine autoinjector
Appearance
![]() | Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Epinephrine autoinjector.
|
This is the talk page for discussing improvements to the Epinephrine autoinjector article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
Archives: 1Auto-archiving period: 90 days ![]() |
![]() | This article is rated C-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||||
|
Missing information
[edit]- Mylan had an agreement with Pfizer, struck in 2010, for Pfizer to disinvest from Adrenaclick, which competed with Mylan's product, EpiPen. Pfizer was purchasing King Pharmaceuticals, which manufactured the drug that went into EpiPen, so giving up the profits from its selling of Adrenaclick would be more than made up for by higher profits from EpiPen sales. - https://theintercept.com/2021/09/07/joe-manchin-epipen-price-heather-bresch/
- Adrenaclick was discontinued - https://snacksafely.com/2018/08/epipen-generic-impax-auto-injector-sorting-through-the-lingo/ .
Categories:
- C-Class medicine articles
- Low-importance medicine articles
- C-Class emergency medicine and EMS articles
- Low-importance emergency medicine and EMS articles
- Emergency medicine and EMS task force articles
- All WikiProject Medicine pages
- C-Class pharmacology articles
- Mid-importance pharmacology articles
- WikiProject Pharmacology articles